Abstract
In the present work, piperic acid and 4-ethylpiperic acid (EPA) amides with amino acids (C1–C8) were bio-evaluated for their antimicrobial activity and biofilm inhibition against Gram-positive and Gram-negative bacterial strains. Among all, EPA-β3,3-Pip(Bzl)-OMe, C2 displayed the potent antimicrobial activity with MIC of 6.25 μg ml–1 against Gram-negative bacteria Escherichia coli. In combination studies, the FIC indices suggested that C1 and C2 have a synergistic effect with ciprofloxacin against E. coli and Bacillus subtilis, whereas C5 exhibited a synergistic effect with ciprofloxacin against all the tested bacteria. The inhibitory effect of amides C1, C2, and C5 on the biofilm formation of test strains was significantly potentiated by co-administration with ciprofloxacin. Furthermore, the effective concentrations of C2 in combination reduced drastically compared to alone for biofilm inhibition. At these concentrations, C2 showed negligible hemolytic and cytotoxic activities.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Hetrick EM, Schoenfisch MH. Reducing implant-related infections: active release strategies. Chem Soc Rev. 2006;35:780–9.
Sharma D, Misba L, Khan AU. Antibiotics versus biofilm: an emerging battleground in microbial communities. Antimicrob Resist Infect Control. 2019;8:1–10.
Nishimura S, Tsurumoto T, Yonekura A, Adachi K, Shindo H. Antimicrobial susceptibility of Staphylococcus aureus and Staphylococcus epidermidis biofilms isolated from infected total hip arthroplasty cases. J Orthop Sci. 2006;11:46–50.
Parrino B, Schillaci D, Carnevale I, Giovannetti E, Diana P, Cirrincione G, et al. Synthetic small molecules as anti-biofilm agents in the struggle against antibiotic resistance. Eur J Med Chem. 2019;161:154–78.
Hoque J, Konai MM, Samaddar S, Gonuguntala S, Manjunath GB, Ghosh C, et al. Selective and broad spectrum amphiphilic small molecules to combat bacterial resistance and eradicate biofilms. Chem Comm. 2015;51:13670–3.
Hoque J, Konai MM, Sequeira SS, Samaddar S, Haldar J. Antibacterial and antibiofilm activity of cationic small molecules with spatial positioning of hydrophobicity: an in vitro and in vivo evaluation. J Med Chem. 2016;59:10750–62.
Konai MM, Haldar J. Lysine-based small molecules that disrupt biofilms and kill both actively growing planktonic and nondividing stationary phase bacteria. ACS Infect Dis. 2015;1:469–78.
Spellberg B, Bartlett JG, Gilbert DN. The future of antibiotics and resistance. N Engl J Med. 2013;368:299–302.
Pletzer D, Coleman SR, Hancock RE. Anti-biofilm peptides as a new weapon in antimicrobial warfare. Curr Opin Microbiol. 2016;33:35–40.
Takooree H, Aumeeruddy MZ, Rengasamy KR, Venugopala KN, Jeewon R, Zengin G, et al. A systematic review on black pepper (Piper nigrum L.): From folk uses to pharmacological applications. Crit Rev Food Sci Nutr. 2019;59:S210–S243.
Atal C, Dubey R, Singh J. Biochemical basis of enhanced drug bioavailability by piperine: evidence that piperine is a potent inhibitor of drug metabolism. J Pharm Exp Ther. 1985;232:258–62.
Qu H, Lv M, Xu H. Piperine: bioactivities and structural modifications. Mini Rev Med Chem. 2015;15:145–56.
Kumar A, Khan IA, Koul S, Koul JL, Taneja SC, Ali I, et al. Novel structural analogues of piperine as inhibitors of the NorA efflux pump of Staphylococcus aureus. J Antimicrob Chemother. 2008;61:1270–6.
Wani NA, Singh S, Farooq S, Shankar S, Koul S, Khan IA, et al. Amino acid amides of piperic acid (PA) and 4-ethylpiperic acid (EPA) as NorA efflux pump inhibitors of Staphylococcus aureus. Bioorg Med Chem Lett. 2016;26:4174–8.
Amin H, Wani NA, Farooq S, Nayak D, Chakraborty S, Shankar S, et al. Inhibition of invasion in pancreatic cancer cells by conjugate of EPA with β3, 3-Pip-OH via PI3K/Akt/NF-kB pathway. ACS Med Chem Lett. 2015;6:1071–4.
Wani NA, Rasool RU, Farooq S, Shankar S, Amin H, Nayak D, et al. Piperic acid amide of β, β‐disubstituted‐β‐amino acid, 2‐(4‐amino‐1‐benzylpiperidin‐4‐yl) acid [β3, 3‐Pip (Bzl)] as cytotoxic and apoptosis inducing agent. ChemistrySelect. 2016;1:3657–60.
Takao K, Miyashiro T, Sugita Y. Synthesis and biological evaluation of piperic acid amides as free radical scavengers and α-glucosidase inhibitors. Chem Pharm Bull. 2015;63:326–33.
Dwivedi D, Singh V. Effects of the natural compounds embelin and piperine on the biofilm-producing property of Streptococcus mutans. J Tradit Complement Med. 2016;6:57–61.
Carneiro VA, de Oliveira ST, Silva RL, de Sousa Duarte H, Silva ML, Matos MN, et al. Antimicrobial and antibiofilm activity of Lys-[Trp6] hy-a1 combined with Ciprofloxacin against Gram-negative bacteria. Protein Pept Lett. 2020;27:1124–31.
Verderosa AD, Mansour SC, la Fuente-Núñez D, Hancock RE, Fairfull-Smith KE. Synthesis and evaluation of ciprofloxacin-nitroxide conjugates as anti-biofilm agents. Molecules. 2016;21:1–16.
Xu X, Xu L, Yuan G, Wang Y, Qu Y, Zhou M. Synergistic combination of two antimicrobial agents closing each other’s mutant selection windows to prevent antimicrobial resistance. Sci Rep. 2018;8:1–7.
Ozsoy N, Can A, Yanardag R, Akev N. Antioxidant activity of Smilax excelsa L. leaf extracts. Food Chem. 2008;110:571–83.
Gopal R, Kim YG, Lee JH, Lee SK, Chae JD, Son BK, et al. Synergistic effects and antibiofilm properties of chimeric peptides against multidrug-resistant Acinetobacter baumannii strains. Antimicrob Agents Chemother. 2014;58:1622–9.
Bazargani MM, Rohloff J. Antibiofilm activity of essential oils and plant extracts against Staphylococcus aureus and Escherichia coli biofilms. Food Control. 2016;61:156–64.
Liu Z, Que F, Liao L, Zhou M, You L, Zhao Q, et al. Study on the promotion of bacterial biofilm formation by a Salmonella conjugative plasmid and the underlying mechanism. PloS One. 2014;9:e109808.
Sun W, Weingarten RA, Xu M, Southall N, Dai S, Shinn P, et al. Rapid antimicrobial susceptibility test for identification of new therapeutics and drug combinations against multidrug-resistant bacteria. Emerg Microbes Infect. 2016;5:1–11.
Hughes D, Karlén A. Discovery and preclinical development of new antibiotics. UPS J Med Sci. 2014;119:162–9.
Acknowledgements
We acknowledge the Council of Scientific and Industrial Research (CSIR), New Delhi, and ICAR, India, for financial assistance under Network Project BSC-120 and GAP2123. We also acknowledge Dr Surrinder Koul for providing 4-ethylpiperic acid. GS is thankful to the Indian Council of Medical Research, while NAW, SS, and JR are thankful to the Council of Scientific and Industrial Research (CSIR), for providing research fellowship. The manuscript bears IIIM Communication No. CSIR-IIIM/IPR/00360.
Author information
Authors and Affiliations
Contributions
NW, JR, SS provided the amides of PA and EPA, which were synthesized under the supervision of RR. MK designed the study. GS did the experimentation and MK analyzed the data. GS and MK wrote the paper, and MK and RR reviewed and edited the manuscript.
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Singh, G., Wani, N.A., Rahim, J.U. et al. Synergistic antimicrobial and antibiofilm activities of piperic acid and 4-ethylpiperic acid amides in combination with ciprofloxacin. J Antibiot 75, 236–242 (2022). https://doi.org/10.1038/s41429-022-00508-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41429-022-00508-8
This article is cited by
-
Phytotherapeutic potential against MRSA: mechanisms, synergy, and therapeutic prospects
Chinese Medicine (2024)